Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-007918
Filing Date
2018-03-19
Accepted
2018-03-19 16:01:24
Documents
2
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1538
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4635
  Complete submission text file 0000899243-18-007918.txt   7513
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Bailey Jeffrey Allen (Reporting) CIK: 0001500210 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 18698714